JOHN GORDON: Open Payments
NPI 1831158351 · CORNING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 64 payments from 14 companies in 2025. Trend: 2023 $703 · 2024 $1,110 · 2025 $1,234
Food & beverage: $1,156Consulting: $44Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $339 |
| GlaxoSmithKline, LLC. | 18 | $218 |
| Amgen Inc. | 10 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $139 |
| GENZYME CORPORATION | 5 | $97 |
| CSL Behring | 4 | $77 |
| ADMA BioManufacturing LLC | 2 | $44 |
| Organon LLC | 1 | $31 |
| PFIZER INC. | 2 | $30 |
| Genentech USA, Inc. | 1 | $23 |
Products named: TEZSPIRE, NUCALA, FASENRA, AIRSUPRA, DUPIXENT, CUVITRU, Haegarda, HYQVIA.
Industry payments across NY — which companies pay providers there.
